Skip to main content
. 2018 May 17;16(1):171–177. doi: 10.3892/etm.2018.6181

Figure 3.

Figure 3.

Effect of IL-31 on human PBMC inflammasome. (A) Secretion of TNF-α in PBMC supernatant with LPS and IL-31 treatment. (B) mRNA expression level of TNF-α on PBMC with or without IL-31 treatment under LPS stimulation. (C) mRNA expression level of NLRP1, NLRP3 and NLRP6 on PBMC with or without IL-31 treatment under LPS stimulation. *P<0.05 and ***P<0.001, as indicated. Experiments were performed in triplicate. PBMC, peripheral blood monocytes; TNF, tumor necrosis factor; LPS, lipopolysaccharide; IL, interleukin; PBS, phosphate-buffered saline.